Outlook Therapeutics (OTLK) Debt Ratio (2015 - 2026)
Outlook Therapeutics (OTLK) reported Debt Ratio of 0.78 for Q1 2026, down 29.1% year-over-year from 1.1 in Q1 2025, and down 14.3% quarter-over-quarter from 0.91 in Q2 2025.
Outlook Therapeutics (OTLK) Debt Ratio (2015 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 10 years of Debt Ratio data on file, last reported at 0.78 in Q1 2026.
- Debt Ratio for Q1 2026 came in at 0.78, down 29.1% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.78 (down 29.1% YoY), and the FY2021 annual result was 0.48, up 941.43% from the prior year.
- Debt Ratio eased to 0.78 in Q1 2026 per OTLK's latest filing, from 0.91 in the prior quarter.
- Over five years, Debt Ratio peaked at 1.1 in Q1 2025 and troughed at 0.51 in Q4 2022.
- A 3-year average of 0.83 and a median of 0.85 in 2025 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2026: Debt Ratio surged 315.81% in 2022, then decreased 29.1% in 2026.
- A 3-year view of Debt Ratio shows it stood at 0.51 in 2022, then surged by 79.81% to 0.91 in 2025, then slipped by 14.3% to 0.78 in 2026.
- Business Quant data shows OTLK's Debt Ratio at 0.78 in Q1 2026, 0.91 in Q2 2025, and 1.1 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.18 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Outlook Therapeutics | 51.13 Mn | 43.39 Mn | -21,888.00 | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Jun 30, 2025 | 0.91 |
| Mar 31, 2025 | 1.10 |
| Dec 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.12 |
| Sep 30, 2021 | 0.48 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.85 |
| Sep 30, 2020 | 0.05 |
| Jun 30, 2020 | 0.02 |
| Mar 31, 2020 | 0.00 |
| Dec 31, 2019 | 0.00 |
| Sep 30, 2019 | 0.39 |
| Jun 30, 2019 | 0.20 |
| Mar 31, 2019 | 0.45 |
| Dec 31, 2018 | 0.01 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.01 |
| Mar 31, 2018 | 0.01 |
| Dec 31, 2017 | 0.38 |